Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN FRANCISCO, June 23, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges DENTSPLY SIRONA Inc. (NASDAQ: XRAY) investors who have suffered over $1 million losses to submit your losses now. A securities...
-
SAN JOSE, Calif., June 23, 2022 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech...
-
Chicago, June 23, 2022 (GLOBE NEWSWIRE) -- According to Arizton’s research report, the global single-use bioprocessing probes and sensors market is expected to grow at a CAGR of 16.32%. The...
-
NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Energy Transfer LP (“”Energy Transfer or the “Company”) (NYSE: ET). Such investors are...
-
NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Apyx Medical Corporation (“Apyx” or the “Company”) (NASDAQ: APYX). Such investors are...
-
TORONTO, June 23, 2022 (GLOBE NEWSWIRE) -- SmartCentres Real Estate Investment Trust (“SmartCentres” or the “Trust”) (TSX:SRU.UN) announced today that the trustees of SmartCentres have declared a...
-
Werner Enterprises to Announce Second Quarter 2022 Earnings and Host Earnings Call on August 3, 2022
OMAHA, Neb., June 23, 2022 (GLOBE NEWSWIRE) -- Werner Enterprises, Inc. (Nasdaq: WERN), a premier transportation and logistics provider, will release its second quarter earnings on Wednesday, August...
-
HOUSTON, June 23, 2022 (GLOBE NEWSWIRE) -- Whitestone REIT (NYSE:WSR) (“Whitestone” or the “Company”) today announced that it will release its financial results for the second quarter ended June 30,...
-
NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Digital Turbine, Inc. (“Digital Turbine” or the “Company”) (NASDAQ: APPS). Such...
-
REDWOOD CITY, Calif., June 23, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on enabling cures with stem cell therapies, today announced that the...